Optiflow Junior

Device Fisher & Paykel Healthcare Limited
Total Payments
$181,300
Transactions
5
Doctors
2
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2021 $60,000 1 0
2020 $66,300 2 0
2018 $55,000 2 2

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $181,300 5 100.0%

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
Physiological Changes with High-Flow Nasal Cannula Compared to Nasal CPAP in Extremely Low Birth Weight Infants Fisher & Paykel Healthcare Limited $60,000 0
Physiological Changes With High Flow Nasal Cannula Compared to Nasal CPAP in Extremely Low Birth Weight Infants FISHER & PAYKEL HEALTHCARE LIMITED $43,454 0
Physiological Changes With High-Flow Nasal Cannula Compared to Nasal CPAP in Extremely Low Birth Weight Infants, NCT03700606 Fisher & Paykel Healthcare Limited $35,000 1
Respiratory Function with NHF and CPAP. Bench studies only. FISHER & PAYKEL HEALTHCARE LIMITED $22,846 0
Study of respiratory parameters during nasal high flow and nasal CPAP therapies Fisher & Paykel Healthcare Limited $20,000 1

Top Doctors Receiving Payments for Optiflow Junior

Doctor Specialty Location Total Records
Unknown San Diego, CA $126,300 3
, M.D Pediatrics San Diego, CA $35,000 1
, MD Pediatrics Philadelphia, PA $20,000 1

About Optiflow Junior

Optiflow Junior is a device associated with $181,300 in payments to 2 healthcare providers, recorded across 5 transactions in the CMS Open Payments database. The primary manufacturer is Fisher & Paykel Healthcare Limited.

Payment data is available from 2018 to 2021. In 2021, $60,000 was paid across 1 transactions to 0 doctors.

The most common payment nature for Optiflow Junior is "Unspecified" ($181,300, 100.0% of total).

Optiflow Junior is associated with 5 research studies, including "Physiological Changes with High-Flow Nasal Cannula Compared to Nasal CPAP in Extremely Low Birth Weight Infants" ($60,000).